Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annmarie L Pacchia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Genes, Chromosomes & Cancer|April 10, 2008
Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarraysY Yi, Norma J Nowak, Annmarie L Pacchia, et al.
Journal of Virology|January 30, 2004
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapyPreetha Biswas, Xi Jiang, Annmarie L Pacchia, et al.
Journal of Biotechnology|September 19, 2006
A HIV-2-based self-inactivating vector for enhanced gene transductionSayandip Mukherjee, Hui-Ling Rose Lee, Annmarie L Pacchia, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Human immunodeficiency virus type 1 latency model for high-throughput screeningSofiya Micheva-Viteva, Annmarie L Pacchia, Yacov Ron, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectorsMichael Oertel, Richard Rosencrantz, Yuan-Qing Chen, et al.
The Journal of Biological Chemistry|April 19, 2011
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitorSofiya Micheva-Viteva, Yoshifumi Kobayashi, Leonard C Edelstein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Genes, Chromosomes & Cancer|April 10, 2008
Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarraysY Yi, Norma J Nowak, Annmarie L Pacchia, et al.
Journal of Virology|January 30, 2004
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapyPreetha Biswas, Xi Jiang, Annmarie L Pacchia, et al.
Journal of Biotechnology|September 19, 2006
A HIV-2-based self-inactivating vector for enhanced gene transductionSayandip Mukherjee, Hui-Ling Rose Lee, Annmarie L Pacchia, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2005
Human immunodeficiency virus type 1 latency model for high-throughput screeningSofiya Micheva-Viteva, Annmarie L Pacchia, Yacov Ron, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectorsMichael Oertel, Richard Rosencrantz, Yuan-Qing Chen, et al.
The Journal of Biological Chemistry|April 19, 2011
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitorSofiya Micheva-Viteva, Yoshifumi Kobayashi, Leonard C Edelstein, et al.
Pageof 1